The company is attending the Wells Fargo 21st Annual Healthcare Conference in Boston, MA on September 10, followed by the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY on September 14.

CEO Chang-Woo Lee and Global Business Division Leader Angela Jihyun Lee are representing CUROGEN at both conferences, where the company will introduce its pipeline to a number of major investors deeply engaged in the healthcare industry and hold further discussions on potential collaboration and partnership opportunities.

These conferences mark a meaningful milestone for CUROGEN, offering the opportunity to deepen relationships with the global investment community and take a further step toward the company's global expansion.